Review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes mellitus patients and their importance in primary care

Jose Luis Górriz, Francesc Xavier Cos Claramunt, Natalia Duque, Arantxa Matali

    Research output: Contribution to journalReview articleResearchpeer-review

    1 Citation (Scopus)

    Abstract

    © 2019 Primary Care Diabetes Europe Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes mellitus (T2DM). Furthermore, CKD confers a considerable increase in the risk of cardiovascular (CV) morbidity and mortality. In line with the need to improve knowledge in this field, this article aims to describe the renal endpoints used in the different cardiovascular outcome trials (CVOTs). The objective is to better know the renal variables used in the different CVOTs in order to optimize the implementation of advances in the prevention of progressive diabetic kidney disease in patients with T2DM in clinical practice.
    Original languageEnglish
    Pages (from-to)485-494
    JournalPrimary Care Diabetes
    Volume13
    Issue number6
    DOIs
    Publication statusPublished - 1 Dec 2019

    Keywords

    • Diabetic kidney disease
    • Diabetic nephropathy
    • Major adverse renal event
    • Primary care
    • Renal endpoints
    • Renal outcome
    • Type 2 diabetes

    Fingerprint Dive into the research topics of 'Review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes mellitus patients and their importance in primary care'. Together they form a unique fingerprint.

    Cite this